We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Denies Amgen's Rehearing Request

Law360 (November 27, 2006, 12:00 AM EST) -- In a setback for drug maker Amgen Inc., the U.S. Court of Appeals for the Federal Circuit has rejected the drug maker’s request that it reconsider a patent infringement ruling partially in favor of rival Aventis Pharmaceuticals Inc.

Amgen wanted a full panel of judges to take a second look at a portion of the court's earlier ruling, issued in August, which reversed a lower court’s decision that Aventis infringed a production patent for the blockbuster anemia drug Epogen.

The lower court ruled that Aventis, along...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.